TY  - CONF

T1  - Abstract P5-15-03:nab-paclitaxel + carboplatin or gemcitabine vs gemcitabine/carboplatin as first-line treatment for patients with triple-negative metastatic breast cancer: Results from the randomized phase 2 portion of the tnAcity trial

JO  - Poster Session Abstracts

PY  - 2017/02/01

AU  - Yardley D

AU  - Coleman R

AU  - Conte P

AU  - Cortes J

AU  - Brufsky A

AU  - Shtivelband M

AU  - Young R

AU  - Bengala C

AU  - Ali H

AU  - Eakel J

AU  - Schneeweiss A et al

ED  - 

DO  - DOI: 10.1158/1538-7445.sabcs16-p5-15-03

PB  - American Association for Cancer Research

Y2  - 2025/10/10

ER  -